Galderma Group AG (GALDY)
OTCMKTS
· Delayed Price · Currency is USD
22.82
+1.10 (5.04%)
Apr 25, 2025, 4:00 PM EDT
Galderma Group AG Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Operating Revenue | 4,410 | 4,082 | 3,760 | 3,417 |
| Other Revenue | 30 | 35 | 63.6 | 28.1 |
| Revenue | 4,440 | 4,117 | 3,824 | 3,445 |
| Revenue Growth (YoY) | 7.85% | 7.66% | 11.00% | - |
| Cost of Revenue | 1,355 | 1,232 | 1,194 | 1,034 |
| Gross Profit | 3,085 | 2,885 | 2,630 | 2,411 |
| Selling, General & Admin | 2,151 | 1,990 | 1,908 | 1,711 |
| Research & Development | 260 | 287 | 315.9 | 342.6 |
| Other Operating Expenses | 3 | 2 | 5.1 | 7.7 |
| Operating Expenses | 2,414 | 2,279 | 2,229 | 2,062 |
| Operating Income | 671 | 606 | 400.9 | 349.5 |
| Interest Expense | -352 | -561 | -398.4 | -352.7 |
| Interest & Investment Income | 12 | 6 | - | - |
| Currency Exchange Gain (Loss) | -11 | -29 | 4.8 | 72.5 |
| Other Non Operating Income (Expenses) | 16 | 31 | 12.9 | -72.8 |
| EBT Excluding Unusual Items | 336 | 53 | 20.2 | -3.5 |
| Merger & Restructuring Charges | -15 | -17 | -33.2 | -38 |
| Asset Writedown | - | -1 | -15.2 | -19 |
| Legal Settlements | -11 | -24 | -23.7 | -19.1 |
| Pretax Income | 310 | 11 | -51.9 | -79.6 |
| Income Tax Expense | 79 | 68 | 45 | 4.6 |
| Earnings From Continuing Operations | 231 | -57 | -96.9 | -84.2 |
| Earnings From Discontinued Operations | - | - | -1.6 | -72 |
| Net Income to Company | 231 | -57 | -98.5 | -156.2 |
| Minority Interest in Earnings | - | - | - | 1.9 |
| Net Income | 231 | -57 | -98.5 | -154.3 |
| Net Income to Common | 231 | -57 | -98.5 | -154.3 |
| Shares Outstanding (Basic) | 238 | 238 | 5,188 | 5,188 |
| Shares Outstanding (Diluted) | 238 | 238 | 5,188 | 5,188 |
| Shares Change (YoY) | 0.10% | -95.42% | - | - |
| EPS (Basic) | 0.97 | -0.24 | -0.02 | -0.03 |
| EPS (Diluted) | 0.97 | -0.24 | -0.02 | -0.03 |
| Free Cash Flow | 360 | 44 | 9.7 | 145.8 |
| Free Cash Flow Per Share | 1.51 | 0.18 | 0.00 | 0.03 |
| Gross Margin | 69.48% | 70.08% | 68.77% | 69.99% |
| Operating Margin | 15.11% | 14.72% | 10.48% | 10.14% |
| Profit Margin | 5.20% | -1.39% | -2.58% | -4.48% |
| Free Cash Flow Margin | 8.11% | 1.07% | 0.25% | 4.23% |
| EBITDA | 891 | 818 | 630 | 567.3 |
| EBITDA Margin | 20.07% | 19.87% | 16.48% | 16.47% |
| D&A For EBITDA | 220 | 212 | 229.1 | 217.8 |
| EBIT | 671 | 606 | 400.9 | 349.5 |
| EBIT Margin | 15.11% | 14.72% | 10.48% | 10.14% |
| Effective Tax Rate | 25.48% | 618.18% | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.